Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) reported Q2 EPS of $0.11, $0.07 better than the analyst estimate of $0.04. Revenue for the quarter came in at $14.4 million versus the consensus estimate of $12.21 million.

Earnings